CDKN2B and acute myeloid leukemia: Together with other DNMTs, DNMT1 was substantially overexpressed in leukemia cells specifically according to leukemia type; likewise, acute myeloid leukemia (AML) cells with methylated p15(INAK4B) expressed higher levels of DNMT1 and DNMT3B [12].